About Technology Issues FAQ

Links

Official Page

Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group

Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.